TRAW icon

Traws Pharma
TRAW

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $22.5M invested in Traws Pharma in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more funds holding in top 10

Funds holding in top 10: →

43% less funds holding

Funds holding: 23 → 13 (-10)

91% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 11

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$741K
2
+$120K
3
+$43.6K
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$13.8K
5
UBS Group
UBS Group
Switzerland
+$11.1K

Top Sellers

1
-$61K
2
-$51K
3
-$26K
4
Creative Planning
Creative Planning
Kansas
-$22K
5
Citadel Advisors
Citadel Advisors
Florida
-$20K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$7.1M
2
$5.99M
3
$3.67M
4
$1.77M
5
$1.47M
6
$1.02M
7
$816K
8
$410K
9
$191K
10
$49K
11
$25K
12
$5K
13
$2K
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–